MORGAN STANLEY PLC/CALL/CENCORA/260/0.1/20.09.24

MORGAN STANLEY PLC/CALL/CENCORA/260/0.1/20.09.24 Stock

DE000ME2CK61

Real-time Bid/Ask 13:03:34 2024-05-23 EDT
0.09 ^EUR / 0.117 ^EUR	+26.83%

Current month	-86.33%
1 month	-88.12%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart CENCORA, INC.

Chart MORGAN STANLEY PLC/CALL/CENCORA/260/0.1/20.09.24

Latest news about CENCORA, INC.

Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney...	12:32pm
The market is good to go until Nvidia’s next quarterly results	09:28am
Walgreens Boots Alliance Sells $400 Million of Cencora Shares	06:18am	MT
Walgreens further cuts stake in drug distributor Cencora	06:21pm	RE

More news

Quotes 5-day view

Date	Price	Change
24-05-23	0.048	-41.46%
24-05-22	0.082	+2.50%
24-05-21	0.08	-15.79%
24-05-20	0.095	-12.04%
24-05-17	0.108	-23.94%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 08:52 am

More quotes

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	CENCORA, INC.
Issuer	Morgan Stanley
WKN	ME2CK6
ISIN	DE000ME2CK61
Date issued	2023-10-20
Strike	260 $
Maturity	2024-09-20 (120 Days)
Parity	10 : 1
Emission price	0.18 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	1.11 €
Lowest since issue	0.048 €
Delta	0.1x
Omega	19.63
Premium	18.72x
Gearing	197.29x
Moneyness	0.8460
Difference Strike	40.07 $
Difference Strike %	+15.41%
Spread	0.028 €
Spread %	23.93%
Theoretical value	0.1025
Implied Volatility	19.76 %
Total Loss Probability	91.94 %
Intrinsic value	0.000000
Present value	0.1025
Break even	261.11 €
Theta	-0.01x
Vega	0.02x
Rho	0.01x

Company Profile

Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).

Sector

More about the company

Ratings for Cencora, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Cencora, Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

216.8 USD

Average target price

255.1 USD

Spread / Average Target

+17.71%

Consensus